News From the Field
Quest for Edible Malarial Vaccine Leads to Other Potential Medical Uses for Algae
April 19, 2013
This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.Can scientists rid malaria from the Third World by simply feeding algae, genetically engineered with a vaccine to mammals? That's the question biologists at the University of California, San Diego, sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission. In a follow-up study, the biologists got their answer: Not yet, although the same method may work as a vaccine against a wide variety of viral and bacterial infections.Full Story
University of California, San Diego
The U.S. National Science Foundation propels the nation forward by advancing fundamental research in all fields of science and engineering. NSF supports research and people by providing facilities, instruments and funding to support their ingenuity and sustain the U.S. as a global leader in research and innovation. With a fiscal year 2020 budget of $8.3 billion, NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and institutions. Each year, NSF receives more than 40,000 competitive proposals and makes about 11,000 new awards. Those awards include support for cooperative research with industry, Arctic and Antarctic research and operations, and U.S. participation in international scientific efforts.